Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

RYTM Stock Forecast, Price Targets, Chart, Dividends & Analysis

Rhythm Pharmaceuticals Inc. logo

Rhythm Pharmaceuticals Inc.

Sector: Healthcare   

Industry: Biotechnology

56.12
 
USD
  
0.64
  
(1.15%)
Previous close: 55.48  Open: 55.59  Bid: 52.0  Ask: 59.06
52 week range    
35.17   
   68.58
Mkt Cap: 3,491 M  Avg Vol (90 Days): 539,865
Peers   
OTIC / 
OTLC / 
OVAT-CA / 
Last updated: Monday 23rd December 2024

Stock Rankings

51
MarketXLS Rank
40
Value
61
Technical
52
Quality
How are these ranks calculated?
Search for a stock

Metrics

Peers

StockDividendMarket Cap (B)PEPrice ($)

ORTH-CA

OTIC

0.0085

OTLC

OVAT-CA

Financials

RYTM Income Statement

Annual
Invalid dateDec-17Dec-18Dec-19Dec-20Dec-21Dec-22Dec-23
AcquisitionExpense62000.0
Amortization of intangibles342000.0774000.0855000.0
Basic EPS from continuing operations-3.86-3.04-1.4-3.47-3.2
Basic EPS total-3.86-3.04-1.4-3.47-3.2
Basic weighted shares outstanding13 M31 M36 M44 M50 M52 M58 M
Cost of sales-180000.0599000.02 M9 M
Depreciation-442000.0834000.0690000.0816000.0896000.0903000.0
DepreciationAndAmortization-442000.0834000.0690000.0816000.0896000.0903000.0
Diluted EPS total-2.83-2.39-3.86-3.04-1.4-3.47-3.2
Diluted normalized net income/share-1.4-3.47-3.2
Diluted weighted shares outstanding12 M62 M36 M44 M50 M52 M58 M
GainOnSaleOfSecurity447000.04 M14 M
GeneralAndAdministrativeExpense-215000.0-359000.037 M46 M68 M92 M118 M
Gross operating profit180000.03 M22 M68 M
Income before tax-34 M-74 M-141 M-134 M-70 M-181 M-184 M
Income taxes564000.0
Interest income-1 M4 M5 M3 M447000.0
InterestExpenseNonOperating5 M14 M
MiscOtherSpecialCharges5 M100 M-790000.0190000.0
Net income from total operations-34 M-148 M-141 M-134 M-70 M-181 M-185 M
NetIncomeCommonStockholders-34 M-148 M-141 M-134 M-70 M-181 M-185 M
NetIncomeContinuousOperations-34 M-148 M-141 M-134 M-70 M-181 M-185 M
NetIncomeExtraordinary-74 M-141 M
NetNonOperatingInterestIncomeExpense-1 M4 M5 M3 M447000.01 M-53000.0
Operating income-32 M-78 M-146 M-137 M-170 M-179 M-184 M
Operating income before depreciation (EBITDA)-33 M-74 M-140 M-133 M-68 M-174 M-168 M
OperatingExpense-32 M-78 M146 M137 M173 M201 M252 M
Other income net-5 M-100 M-790000.0190000.0
OtherGandA-215000.0-359000.037 M46 M68 M92 M118 M
OtherOperatingExpenses-32 M-78 M629000.0551000.0551000.0551000.0551000.0
OtherWriteOff95000.01 M12 M
RentAndLandingFees-215000.0-359000.0
Research & development expense23 M50 M109 M90 M104 M109 M135 M
ResearchExpense23 M50 M109 M90 M104 M109 M135 M
Revenue per share342000.0774000.0855000.0
Selling Gen & administrative expense10 M28 M37 M46 M68 M92 M118 M
SellingAndMarketingExpense10 M28 M
SellingExpense10 M28 M
Total Income available for interest expense (EBIT)-34 M-74 M-141 M-134 M-70 M-176 M-170 M
Total common shares outstanding27 M34 M44 M50 M50 M57 M60 M
Total net income-34 M-148 M-141 M-134 M-70 M-181 M-185 M
Total ordinary shares61 M61 M61 M61 M61 M61 M61 M
Total revenues3 M24 M77 M
TotalExpenses32 M-78 M146 M137 M173 M203 M262 M
TotalRevenue3 M24 M77 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu

StockKevin.com

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.

Dave

Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University